Tradestie Institutional Equity Comparison Engine

AAL vs CDT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AAL Overall Edge

AAL Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to American Airlines Group Inc. (AAL) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AAL trades at 10.9x Forward P/E with 1.8% operating margin (+19.3% YoY revenue) versus CDT at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, AAL sits in BREAKDOWN (22nd %ile IV; Dealer Gamma Walls on Pro) against CDT sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner AAL
AAL 10.9x vs CDT N/M Fwd P/E
Growth & Margin Winner AAL
Op Margin 1.8% vs 0.0% ยท YoY +19.3% vs +0.0%
Momentum & Technical Winner AAL
1Y -3.5% vs -86.8% ยท 52W Pos 21% vs 2%
Options & Structure Winner AAL
BREAKDOWN (22nd %ile IV) vs BREAKDOWN (N/A IV)
AAL NASDAQ
American Airlines Group Inc.
Air Transportation, Scheduled
$11.90
-6.45% 1D
Market Cap $8.4B
1M Return -5.56%
1Y Return -3.49%
Forward P/E 10.9x
Unified AI Score
44.7 / 100 HOLD
Tech 25.0 Fund 45.0 Flow 58.0 Mom 60.0
CDT NASDAQ
CDT Equity Inc. Common Stock
Pharmaceutical Preparations
$0.23
-13.89% 1D
Market Cap $507,528
1M Return +76.79%
1Y Return -86.78%
Forward P/E N/M
Unified AI Score
31.6 / 100 SELL
Tech 15.0 Fund 37.0 Flow 50.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AAL -3.49% CDT -86.78% Spread: +83.29 pp (AAL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AAL TTM Op. Margin: 1.8% CDT TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AAL vs CDT. Trailing 12-month operating profitability (AAL 1.8% vs CDT 0.0%) and valuation multiples (AAL 10.9x vs CDT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AAL (9) vs CDT (1)
Institutional Metric AAL CDT Criterion Row Winner
Market Capitalization Scale $8.4B $507,528 Larger Scale AAL
Trailing P/E Ratio Valuation 11.2x N/M Lower Multiple AAL
Forward P/E Ratio Valuation 10.9x N/M Lower Multiple AAL
Revenue Growth (YoY) Growth +19.3% +0.0% Higher Growth AAL
Operating Margin (TTM) Profitability 1.8% 0.0% Higher Margin AAL
Net Profit Margin Profitability -0.8% 0.0% Higher Margin CDT
Return on Equity (ROE) Capital Efficiency 0.0% -69.7% Higher ROE AAL
52-Week Range Position Momentum 21% ($10โ€“$19) 2% ($0โ€“$11) Stronger Trend AAL
Beta / 30D Volatility Risk Regime 1.82ฮฒ ยท 55% Vol -17.75ฮฒ ยท 10175% Vol Lower Realized Risk AAL
Unified Institutional Score Composite Signal 44.7 / 100 (HOLD) 31.6 / 100 (SELL) Higher Composite AAL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AAL vs CDT Buy Guide
AAL BREAKDOWN
105d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 22nd %ile
IV Regime Compressed (<25th %ile)
Live AAL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CDT BREAKDOWN
163d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CDT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AAL nor CDT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.